The World Bank Implementation Status & Results Report Lesotho COVID-19 Emergency Preparedness and Response Project (P173939) Lesotho COVID-19 Emergency Preparedness and Response Project (P173939) AFRICA EAST | Lesotho | Health, Nutrition & Population Global Practice | IBRD/IDA | Investment Project Financing | FY 2020 | Seq No: 4 | ARCHIVED on 31-Jan-2022 | ISR47909 | Implementing Agencies: Kingdom of Lesotho, Ministry of Health Key Dates Key Project Dates Bank Approval Date: 09-May-2020 Effectiveness Date: 27-May-2020 Planned Mid Term Review Date: -- Actual Mid-Term Review Date: Original Closing Date: 30-Jun-2022 Revised Closing Date: 30-Jun-2024 pdoTable Project Development Objectives Project Development Objective (from Project Appraisal Document) To prevent, detect and respond to the threat posed by COVID-19 to the Kingdom of Lesotho. Has the Project Development Objective been changed since Board Approval of the Project Objective? No Components Table Name Component 1: Emergency COVID-19 Response:(Cost $29675000.00 M) Component 2: Project Implementation and Monitoring & Evaluation:(Cost $3325000.00 M) Overall Ratings Name Previous Rating Current Rating Progress towards achievement of PDO Satisfactory Satisfactory Overall Implementation Progress (IP) Satisfactory Satisfactory Overall Risk Rating High High Implementation Status and Key Decisions The Lesotho COVID-19 Emergency Preparedness and Response Project aim to support the Government of Lesotho’s (GOL) effort to prevent, detect and respond to the threat posed by COVID-19. The project is aligned to the GOL’s COVID-19 National Integrated Response Plan and complements support from other development partners. The project became effective on May 27, 2020. An Additional Financing for vaccine procurement and deployment as well as for activities to continue to support the COVID-19 response was approved on June 1, 2021. Implementation is proceeding as planned. The project has disbursed US$12.78 million to date. Among others, the project has supported the procurement and deployment of COVID-19 vaccines as well as the procurement of critical equipment and medical supplies such as personal protective equipment for hospitals and health care workers, supported additional human resources and training, both for specialized and for community health workers, and supported the refurbishment of the Mafeteng COVID-19 treatment center, which provides critical medical care for COVID-19 patients in the district of Mafeteng and the country. 1/31/2022 Page 1 of 7 The World Bank Implementation Status & Results Report Lesotho COVID-19 Emergency Preparedness and Response Project (P173939) MPA Program Development Objective MPA PDO Table The Program Development Objective is to prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness MPA Table Multiphase Programmatic Approach (MPA) Status MPA Table Body The Additional Financing (MPA AF-V) to the COVID-19 Strategic Preparedness and Response Program utilizing the Multiphase Programmatic Approach (“Global COVID-19 MPA”) was approved by the Board on October 13, 2021. The AF-V is significantly expanding Bank support to client countries for COVID-19 vaccination, with the aim to support vaccination of 1 billion people globally. The AF-V was approved with an envelope of US$12 billion ($6 billion from IDA and $6 billion from IBRD) in financing. This financing is critical to expanding affordable and equitable financing for vaccine purchase and deployment. The AF-V is expected to enable vaccination for up to 750 million people, with potential surge capacity for an additional 250 million people in the poorest countries (depending on the delivered price of approved vaccines) while scaling support to strengthen immunization delivery, with design flexibility at the country level. The AF-V is a scale-up of planned vaccination activities anticipated and supported under the Global COVID-19 MPA and a key contribution to the WBG’s overall COVID-19 response. As of January 17, 2022, the Bank has approved 83 operations to support vaccine procurement and rollout in 69 countries amounting to $7.6 billion. The 83 AF-V operations approved, include 6 operations that involved restructuring of parent projects (Bhutan, Cameroon, North Macedonia, Philippines, and Pakistan) and in the case of Lebanon, restructuring of the Health Resilience Project. Of the 83 approved operations: (i) 45 are in Africa – 21 in AFE and 24 in AFW; (ii) 8 in East Asia; (iii) 9 in Europe and Central Asia; (iv) 6 in Latin America and the Caribbean; (v) 7 in the Middle East and North Africa; and (vi) 8 in South Asia. Forty-three (43) projects are disbursing. Thirty new operations are under various stages of processing. Total disbursements as of January 17, 2022, under these projects, amount to US$1.8 billion or 24% of overall commitments. As with the MPA operations, streamlined procedures, delegated approval, coupled with flexible project design and intensified efforts across the Bank have contributed to the rapid design and processing of the operations. Seventy (70) loan/financing agreements have been signed. Also, sixty (60) loan/financing agreements have become effective; several others are expected to become effective in the coming weeks. Implementation of the AF- V operations, as with MPA operations is facing challenges as several countries are still under different levels of lockdown or mobility restrictions and counterparts and Bank teams are operating from home. Countries are dealing with new waves of infections as the Omicron variant is spreading rapidly among populations. The variant, which was first identified in South Africa and Botswana, has been detected in more than 80 nations by mid- December 2021. Risks Systematic Operations Risk-rating Tool Risk Category Rating at Approval Previous Rating Current Rating Political and Governance Substantial Substantial Substantial Macroeconomic Substantial Moderate Moderate Sector Strategies and Policies Substantial Substantial Substantial Technical Design of Project or Program Substantial Low Low Institutional Capacity for Implementation and Substantial Substantial Substantial Sustainability 1/31/2022 Page 2 of 7 The World Bank Implementation Status & Results Report Lesotho COVID-19 Emergency Preparedness and Response Project (P173939) Fiduciary Substantial High High Environment and Social Substantial Substantial Substantial Stakeholders Moderate Moderate Moderate Other -- -- -- Overall Substantial High High Results PDO Indicators by Objectives / Outcomes Emergency COVID-19 Response IN01029302 ►Diagnosed cases treated per approved protocol (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 93.00 99.60 90.00 Date 27-Apr-2020 12-Apr-2021 16-Nov-2021 30-Jun-2024 IN01029303 ►Total population vaccinated (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 0.00 23.00 50.00 Date 16-Apr-2021 16-Apr-2021 16-Nov-2021 30-Jun-2024 IN01029304 Total female population vaccinated (Percentage, Custom Supplement) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 0.00 27.00 50.00 IN01029305 Total male population vaccinated (Percentage, Custom Supplement) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 0.00 18.00 50.00 IN01029306 ►COVID-19 PCR tests processed within two days (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 15.00 15.00 100.00 70.00 Date 16-Apr-2021 16-Apr-2021 16-Nov-2021 30-Jun-2024 1/31/2022 Page 3 of 7 The World Bank Implementation Status & Results Report Lesotho COVID-19 Emergency Preparedness and Response Project (P173939) Intermediate Results Indicators by Components Emergency COVID-19 Response IN01029307 ►Grievances addressed on time (as specified in the Stakeholder Engagement Plan) (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 100.00 100.00 100.00 Date 01-Dec-2020 12-Apr-2021 16-Nov-2021 30-Jun-2024 IN01029308 ►Doses of eligible COVID-19 vaccines procured (Number, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 0.00 151,000.00 800,000.00 Date 19-Apr-2021 19-Apr-2021 19-Apr-2021 30-Jun-2024 IN01029309 ►Health staff trained in COVID-19 vaccination deployment per MOH-approved protocols (Number, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 0.00 270.00 400.00 Date 19-Apr-2021 19-Apr-2021 16-Nov-2021 30-Jun-2024 IN01029310 Female health staff trained in COVID-19 vaccination deployment per MOH-approved protocols (Number, Custom Breakdown) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 0.00 211.00 300.00 Date 19-Apr-2021 19-Apr-2021 16-Nov-2021 30-Jun-2024 IN01029311 Male health staff trained in COVID-19 vaccination deployment per MOH-approved protocols (Number, Custom Breakdown) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 0.00 59.00 100.00 Date 19-Apr-2021 19-Apr-2021 16-Nov-2021 30-Jun-2024 IN01029312 ►A patient feedback mechanism for COVID-19 vaccinations is in place and functional (Yes/No, Custom) Baseline Actual (Previous) Actual (Current) End Target Value No No No Yes 1/31/2022 Page 4 of 7 The World Bank Implementation Status & Results Report Lesotho COVID-19 Emergency Preparedness and Response Project (P173939) Date 19-Apr-2021 19-Apr-2021 16-Nov-2021 30-Jun-2024 IN01029313 ►COVID-19 related information and education sessions targeting women (Number, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 0.00 53.00 500.00 Date 19-Apr-2021 19-Apr-2021 16-Nov-2021 30-Jun-2024 IN01029314 ►Serious AEFI after COVID-19 vaccination investigated (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 0.00 92.00 95.00 Date 19-Apr-2021 19-Apr-2021 16-Nov-2021 30-Jun-2024 IN01029315 ►Intensive Care Units refurbished (Number, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 1.00 1.00 1.00 3.00 Date 19-Apr-2021 19-Apr-2021 16-Nov-2021 30-Jun-2024 IN01029316 ►National Reference Laboratory is expanded, equipped and functional (Yes/No, Custom) Baseline Actual (Previous) Actual (Current) End Target Value No No No Yes Date 19-Apr-2021 19-Apr-2021 16-Nov-2021 30-Jun-2024 IN01029317 ►Health staff trained in COVID-19 case management per MOH-approved protocols (Number, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 0.00 0.00 85.00 Date 19-Apr-2021 19-Apr-2021 16-Nov-2021 30-Jun-2024 IN01029318 ►Oxygen plants established (Number, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 0.00 0.00 2.00 Date 19-Apr-2021 19-Apr-2021 16-Nov-2021 30-Jun-2024 1/31/2022 Page 5 of 7 The World Bank Implementation Status & Results Report Lesotho COVID-19 Emergency Preparedness and Response Project (P173939) Performance-Based Conditions Data on Financial Performance Disbursements (by loan) Project Loan/Credit/TF Status Currency Original Revised Cancelled Disbursed Undisbursed % Disbursed P173939 IDA-66770 Effective USD 7.50 7.50 0.00 6.72 0.78 90% P173939 IDA-69300 Effective USD 22.00 22.00 0.00 8.45 13.16 39% P173939 TF-B5779 Effective USD 3.50 3.50 0.00 0.92 2.58 26% Key Dates (by loan) Project Loan/Credit/TF Status Approval Date Signing Date Effectiveness Date Orig. Closing Date Rev. Closing Date P173939 IDA-66770 Effective 09-May-2020 12-May-2020 27-May-2020 30-Jun-2022 30-Jun-2022 P173939 IDA-69300 Effective 01-Jun-2021 11-Jun-2021 30-Jun-2021 30-Jun-2024 30-Jun-2024 P173939 TF-B5779 Effective 02-Jun-2021 11-Jun-2021 30-Jun-2021 30-Jun-2024 30-Jun-2024 Cumulative Disbursements 1/31/2022 Page 6 of 7 The World Bank Implementation Status & Results Report Lesotho COVID-19 Emergency Preparedness and Response Project (P173939) PBC Disbursement Achievement Disbursed amount in Disbursement % PBC ID PBC Type Description Coc PBC Amount Status Coc for PBC Restructuring History There has been no restructuring to date. Related Project(s) P176307-AF Lesotho COVID-19 Emergency Preparedness and Response Project 1/31/2022 Page 7 of 7